Pediatric influenza immunization

References

• Fowlkes AL, Arguin P, Biggerstaff MS et al. Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April–July 2009. Clin. Infect. Dis.52(Suppl. 1), S60–S68 (2011).
   Google Scholar
• Brotherton J, McIntyre P, Puech M et al. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Commun. Dis. Intell.28(Suppl. 2), VII–S116 (2004).
   Google Scholar
• Wu JT, Ma ES, Lee CK et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin. Infect. Dis.51(10), 1184–1191 (2010).
   PubMed Web of Science ®Google Scholar
• Bekker A, Chou C, Bernstein HH. Update on universal annual influenza immunization recommendations for children. Curr. Opin. Pediatr.21(1), 122–126 (2009).
   PubMed Web of Science ®Google Scholar
• Dowdle WR, Millar JD, Schonberger LB, Ennis FA, LaMontagne JR. Influenza immunization policies and practices in Japan. J. Infect. Dis.141(2), 258–264 (1980).
   PubMed Web of Science ®Google Scholar
• Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N. Engl. J. Med.344(12), 889–896 (2001).
   PubMed Web of Science ®Google Scholar
• Longini IM, Jr., Koopman JS, Haber M, Cotsonis GA. Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. Am. J. Epidemiol.128(4), 845–859 (1988).
   PubMed Web of Science ®Google Scholar
• Elveback LR, Fox JP, Ackerman E, Langworthy A, Boyd M, Gatewood L. An influenza simulation model for immunization studies. Am. J. Epidemiol.103(2), 152–165 (1976).
   PubMed Web of Science ®Google Scholar
• Lewis EN, Griffin MR, Szilagyi PG, Zhu Y, Edwards KM, Poehling KA. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics120(3), 467–472 (2007).
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst. Rev. (2), CD004879 (2008).
   PubMedGoogle Scholar
• Mullins RJ, Kemp A, Gold M. Influenza vaccination of the egg-allergic individual. Med. J. Aust.193(5), 254–255 (2010).
   PubMed Web of Science ®Google Scholar
• Baxter R, Patriarca PA, Ensor K, Izikson R, Goldenthal KL, Cox MM. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok(®) trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50–64 years of age. Vaccine29(12), 2272–2278 (2011).
   PubMed Web of Science ®Google Scholar
• Bright RA, Carter DM, Daniluk S et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine25(19), 3871–3878 (2007).
   PubMed Web of Science ®Google Scholar
• Landry N, Ward BJ, Trepanier S et al. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS ONE5(12), e15559 (2010).
   PubMed Web of Science ®Google Scholar
• Frey S, Vesikari T, Szymczakiewicz-Multanowska A et al. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin. Infect. Dis.51(9), 997–1004 (2010).
   PubMed Web of Science ®Google Scholar
• Kendal AP. Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries? Eur. J. Epidemiol.13(5), 591–609 (1997).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Mendelman PM, Treanor J et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N. Engl. J. Med.338(20), 1405–1412 (1998).
   PubMed Web of Science ®Google Scholar
• Vesikari T. Emerging data on the safety and efficacy of influenza vaccines in children. Pediatr. Infect. Dis. J.27(Suppl. 11), S159–S161 (2008).
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Wu X, Belshe RB. The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination. Pediatr. Infect. Dis. J.29(9), 806–811 (2010).
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Ross TM. Challenges in improving influenza vaccine protection in the elderly. Expert Rev. Vaccines10(1), 7–11 (2011).
   PubMed Web of Science ®Google Scholar
• El’shina GA, Gorbunov MA, Bektimirov TA et al. The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren. Zh. Mikrobiol. Epidemiol. Immunobiol.2, 50–54 (2000).
   Google Scholar
• Herzog C, Hartmann K, Kunzi V et al. Eleven years of Inflexal V – a virosomal adjuvanted influenza vaccine. Vaccine27(33), 4381–4387 (2009).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Pellegrini M, Karvonen A et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr. Infect. Dis. J.28(7), 563–571 (2009).
   PubMed Web of Science ®Google Scholar
• Walker WT, Faust SN. Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine. Expert Rev. Vaccines9(12), 1385–1398 (2010).
   PubMed Web of Science ®Google Scholar
• Gasparini R, Schioppa F, Lattanzi M et al. Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria) in adult and elderly subjects. Int. J. Clin. Pract.64(4), 432–438 (2010).
   PubMed Web of Science ®Google Scholar
• Waddington CS, Walker WT, Oeser C et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ340, c2649 (2010).
   PubMed Web of Science ®Google Scholar
• European Medicines Agency updates on the review of Pandemrix and reports of narcolepsy. Euro Surveill.15(38), pii: 19670 (2010).
   Google Scholar
• Montastruc JL, Durrieu G, Rascol O. Pandemrix degrees, (H1N1)v influenza and reported cases of narcolepsy. Vaccine DOI:10.1016/j.vaccine.2010.12.092 (2011) (Epub ahead of print).
   Google Scholar
• Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010–2011. MMWR Morb. Mortal. Wkly Rep.59(31), 989–992 (2010).
   PubMedGoogle Scholar
• Kelly H, Carcione D, Dowse G, Effler P. Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010. Euro Surveill.15(37), 19661 (2010).
   PubMedGoogle Scholar